ICoNS provides a unique platform where all global stakeholders can contribute to this vital conversation. I invite you to join our monthly meetings held the first Wednesday of each month, where we address these pressing challenges together: https://t.co/b65l09yqyx #ICoNS
Last week's expert panel on "Privacy, Trust, and the Fallout from the 23andMe Bankruptcy" tackled the future of genetic privacy head-on. Join us monthly as our global consortium unpacks the biggest challenges in genomic newborn screening. https://t.co/TOeL0VhSOf #ICoNS#genomics
🧬We’re thrilled to announce the first International Conference on Newborn Sequencing (ICoNS) in Boston (in-person and virtual options) on October 5 & 6, 2022. Stay tuned for more information and registration details! Please contact [email protected] with any questions.
#GeneChat
Our work strives to improve public health. Our newly launched Precision Population Health Initiative with @AriadneLabs is just one way we are dedicated to #PublicHealthGenetics. https://t.co/jneAEbr4No
"Precision medicine is primed to bridge the divide between specialty care and everywhere else in medicine" writes @nicencina, Director of Strategy of the Precision Population Health collaboration with @Genomes2People#PublicHealthGenetics
https://t.co/7tsuAnv1MH
"You have to have the discipline to say, 'Fundamentally, what problem are we trying to solve?'" @AriadneLabs' Nicolas Encina '10 #Innovation#YaleSOMAlumni https://t.co/ANX0HHu1xU